STMN1 and breast cancer: Altogether, these data suggest that mutant p53R175H downregulated miR-223, which in turn upregulates STMN1 expression leading to cancer cell resistance to chemotherapy in colon and breast cancer cell lines (Masciarelli et al., 2014).